chp vaccination 相關
廣告
搜尋結果
4 天前 · Saint Herblain (France), May 31, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending authorization of Valneva’s single-dose vaccine for the prevention of...
5 天前 · 盧寵茂說，去年施政報告宣布，特區政府會優化現行的藥物審批和註冊制度，在6個月內已取得一定成果，包括實施新的藥物審批機制即「1+」機制。 特區政府今年上半年內會成立「香港藥物及醫療器械監督管理中心」籌備辦公室，就重整及加強藥械及技術監管和審批制度作研究，為成立管理中心並邁向「第一層審批」提出建議和步驟。 他又說，特區政府今年年底前會於河套成立「大灣區國際臨床試驗所」，提供一站式臨床試驗支援服務，推動本港成為亞洲區領先的臨床試驗中心。 盧寵茂鼓勵瑞士藥廠善用「1+」機制，將新研發藥物引入香港以應付本地醫療需要，並透過「港澳藥械通」的安排惠及粵港澳大灣區內地城市的病人。 他亦歡迎瑞士藥廠來港進行臨床試驗，以促進先進生物醫藥技術的轉化和臨床應用。 你可能喜歡.
4 天前 · Forde, May 31, 2024 (GLOBE NEWSWIRE) — In the contemporary business world, the shift towards remote and hybrid work models is one of the most profound changes organizations have faced. As a leader in innovation and strategic business solutions, EarlyBirds is at the forefront of assisting organizations to navigate and optimize this transition.
4 天前 · Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine 05月31日 15:35 GlobeNewswire If approved, IXCHIQ® will become the first vaccine available in the EU against the chikungunya virus Decision on EU marketing authorization expected in the third quarter of 2024 Saint Herblain , May 31, 2024 – Valneva SE , a ...
5 天前 · 05月30日 15:00 GlobeNewswire. Telecommunications and industry expert joins Truepic mission to enhance the transparency of digital content online across industry and government. Tom Wheeler Joins Truepic. Truepic has announced the addition of Tom Wheeler to its industry Board of Advisors. San Diego, CA, May 30, 2024 (GLOBE NEWSWIRE ...
4 天前 · OSE Immunotherapeutics Provides Business and Corporate Update. Three pharmaceutical agreements signed during the last three months: New strategic partnership with AbbVie for OSE-230, a novel preclinical potential first-in-class program for the treatment of chronic inflammation. Major partnership expansion with Boehringer Ingelheim:
5 天前 · WASHINGTON, May 30, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the e...
